Samuel C. Blackman Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

DAWN Quotes by TradingView

Samuel C. Blackman is HEAD OF R&D of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 1.03 Million shares of DAWN, which is worth approximately $8.34 Million. The most recent transaction as insider was on Jun 05, 2023, when has been sold 1,229 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $19,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.03M
0% 3M change
12.72% 12M change
Total Value Held $8.34 Million

Samuel C. Blackman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2023
SELL
Open market or private sale
$19,664 $16.0 p/Share
1,229 Reduced 0.1%
1,234,363 Common Stock
May 16 2023
SELL
Open market or private sale
$9,079 $13.12 p/Share
692 Reduced 0.06%
1,235,592 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
-
2,624 Added 0.21%
1,236,284 Common Stock
Mar 10 2023
SELL
Open market or private sale
$180,500 $18.05 p/Share
10,000 Reduced 0.8%
1,233,660 Common Stock
Feb 16 2023
SELL
Open market or private sale
$13,190 $19.57 p/Share
674 Reduced 0.05%
1,243,660 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
2,624 Added 0.21%
1,244,334 Common Stock
Feb 10 2023
SELL
Open market or private sale
$200,700 $20.07 p/Share
10,000 Reduced 0.8%
1,241,710 Common Stock
Jan 10 2023
SELL
Open market or private sale
$229,800 $22.98 p/Share
10,000 Reduced 0.79%
1,250,148 Common Stock
Dec 01 2022
SELL
Open market or private sale
$217,700 $21.77 p/Share
10,000 Reduced 0.79%
1,260,148 Common Stock
Nov 16 2022
SELL
Open market or private sale
$8,090 $21.46 p/Share
377 Reduced 0.03%
1,270,148 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
-
1,187 Added 0.09%
1,270,525 Common Stock
Nov 01 2022
SELL
Open market or private sale
$200,000 $20.0 p/Share
10,000 Reduced 0.78%
1,269,338 Common Stock
Oct 03 2022
SELL
Open market or private sale
$199,900 $19.99 p/Share
10,000 Reduced 0.78%
1,279,338 Common Stock
Sep 01 2022
SELL
Open market or private sale
$234,700 $23.47 p/Share
10,000 Reduced 0.77%
1,289,338 Common Stock
Aug 16 2022
SELL
Open market or private sale
$22,876 $24.31 p/Share
941 Reduced 0.07%
1,299,338 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
-
3,561 Added 0.27%
1,300,279 Common Stock
Aug 01 2022
SELL
Open market or private sale
$168,800 $16.88 p/Share
10,000 Reduced 0.77%
1,296,718 Common Stock
Jul 01 2022
SELL
Open market or private sale
$191,400 $19.14 p/Share
10,000 Reduced 0.76%
1,306,718 Common Stock
Jun 15 2022
SELL
Open market or private sale
$813,000 $16.26 p/Share
50,000 Reduced 3.66%
1,316,718 Common Stock
Jan 03 2022
SELL
Open market or private sale
$171,800 $17.18 p/Share
10,000 Reduced 0.73%
1,366,718 Common Stock
Dec 01 2021
SELL
Open market or private sale
$175,600 $17.56 p/Share
10,000 Reduced 0.72%
1,376,718 Common Stock
Oct 22 2021
SELL
Bona fide gift
-
1,000,000 Reduced 41.9%
1,386,718 Common Stock
SCB

Samuel C. Blackman

HEAD OF R&D
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DAWN